Jupiter Life Line Hospitals Ltd (JLHL) Q1FY26 Concall Summary - Jun-2025 Qtr
Performance Overview
- Jupiter Life Line Hospitals reported a 20.5% YoY increase in total income, reaching INR 347.6 crores, which includes INR 6.6 crores from Jupiter Pharmacy.
- EBITDA grew by 19.6% YoY to INR 78.1 crores, with a margin of 22.5%.
- PAT saw a slight decline of 1.6% YoY, amounting to INR 43.9 crores, with a margin of 12.6%.
- The company commissioned a new 1.2 megawatt solar power plant in Madhya Pradesh, increasing its total renewable energy capacity to 6.8 megawatts.
- Three greenfield hospital projects (Dombivli, Pune, and Mira Road) are progressing as planned.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.